Warnings and precautions ask all professionals to remove their masks before giving any explanation . masking the truth is what your hearing or just becoming deaf
Talk to your doctor, pharmacist or nurse before you are given the vaccine if you have:
• ever had a severe allergic reaction or breathing problems after any other vaccine injection or
after you were given COVID-19 mRNA Vaccine BNT162b2 in the past.
• a severe illness with high fever
However, a mild fever or upper airway infection, like a cold, are not reasons to delay
vaccination.
• a weakened immune system, such as due to HIV infection, or are on a medicine that affects
your immune system
• a bleeding problem, bruise easily or use a medicine to inhibit blood clotting
As with any vaccine, COVID-19 mRNA Vaccine BNT162b2 may not fully protect all those who
receive it. No data are currently available in individuals with a weakened immune system or who are
taking chronic treatment that suppresses or prevents immune responses.
Children and adolescents
COVID-19 mRNA Vaccine BNT162b2 is not recommended for children under 16 years.
Other medicines and COVID-19 mRNA Vaccine BNT162b2
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines
or have recently received any other vaccine.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask
your doctor or pharmacist for advice before you receive this vaccine.
Driving and using machines
COVID-19 mRNA Vaccine BNT162b2 has no or negligible influence on the ability to drive and use
machines. However, some of the effects mentioned under section 4 ‘Possible side effects’ may
temporarily affect the ability to drive or use machines. Do not drive or operate machinery until you are
sure that you are not affected.
COVID-19 mRNA Vaccine BNT162b2 contains sodium and potassium
This vaccine contains potassium, less than 1 mmol (39 mg) per dose, i.e. essentially ‘potassium-free’.
This vaccine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodiumfree’.
3. How COVID-19 mRNA Vaccine BNT162b2 is given
COVID-19 mRNA Vaccine BNT162b2 is given after dilution as an injection of 0.3 mL into a muscle
of your upper arm.
You will receive 2 injections, given at least 21 days apart.
If you receive one dose of COVID-19 mRNA Vaccine BNT162b2, you should receive a second dose
of the same vaccine at least 21 days later to complete the vaccination series. Protection against
COVID-19 disease may not be maximally effective until at least 7 days after the second dose.
If you have any further questions on the use of COVID-19 mRNA Vaccine BNT162b2, ask your
doctor, pharmacist or nurse its a choice